ProCE Banner Activity

Multiple Myeloma: 2019 Treatment Algorithm and Clinical Trial Spotlight

PDF
Download this 2019 treatment algorithm that includes a list of key ongoing or enrolling clinical trials to help select optimal treatment options for your patients with myeloma.

Released: August 22, 2019

Expiration: August 20, 2020

No longer available for credit.

Share

Faculty

Ajai Chari

Ajai Chari, MD

Director of Multiple Myeloma Program
Professor of Clinical Medicine
University of California- San Francisco
San Francisco, California

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Amgen, Inc.

Celgene

Janssen administered by Scientific Affairs

Oncopeptides

Faculty Disclosure

Primary Author

Ajai Chari, MD

Director of Multiple Myeloma Program
Professor of Clinical Medicine
University of California- San Francisco
San Francisco, California

Ajai Chari, MD, has disclosed that he has received consulting fees from Amgen, Bristol-Myers Squibb, Celgene, Janssen, Karyopharm, Novartis, and Takeda; funds for research support from Amgen, Array, Celgene, GlaxoSmithKline, Janssen, Novartis, Pharmacyclics, Oncoceutics, Seattle Genetics, and Takeda; and has served on the scientific advisory board for Amgen, Celgene, Janssen, Karyopharm, Novartis, Oncopeptides, Sanofi, Seattle Genetics, and Takeda.